New Metabolic Disease Articles from our Partners at Consultant 360

Baseline LDL-C Levels Impact Effectiveness of CVD Risk Reduction

http://bit.ly/2HQahwK

In a recent meta-analysis of 34 trials and more than 270,000 participants, the authors aimed to compare the effects of more and less intensive LDL-C lowering on both all-cause and cardiovascular-specific mortality, and how baseline levels of LDL-C affected the success of these risk reduction strategies.

US Alcohol Guidelines Not Strict Enough

http://bit.ly/2r1ijJF

Low-risk recommendations for alcohol consumption vary greatly across different national guidelines, and new research suggests that the upper limits of alcohol consumption in these guidelines may not be low enough.

Ambulatory vs Clinic BP: Which Best Predicts Mortality Risk?

http://bit.ly/2JuHQlg

In a new study of more than 63,000 adults, researchers compared the effectiveness of ambulatory and clinic BP readings for predicting the risks of all-cause and cardiovascular mortality for various categories of BP.

Initial BP Measurements Are Often Misleading

http://bit.ly/2Fj5NJu

The AHA recommends repeated BP measurements during clinic visits, but in busy practices, it is often only measured once. In a study of 38,260 patients, researchers investigated the impact of a second reading on BP control in patients with hypertension.

Women Still Less Likely to Receive Statins, Despite Guidelines

http://bit.ly/2I1Qlok

Researchers aimed to update trends in statin prescription following hospitalization for myocardial infarction, especially in light of recent efforts geared toward reducing potential treatment disparities in this patient population.